Announcements Trials
Browse Landscape

Phase

Phase 1 19Phase 2 17Phase 1/2 5Phase NA 4Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 65Lymphoid 2Thoracic 1Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Lymphoma 39Lymphoma, Non-Hodgkin 37Lymphoma, B-Cell 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Burkitt Lymphoma 27Lymphoma, Large B-Cell, Diffuse 21Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, Mantle-Cell 15Leukemia 13Recurrence 12Multiple Myeloma 12Hodgkin Disease 12Leukemia, Myeloid, Acute 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, T-Cell 9Myelodysplastic Syndromes 8Lymphoma, T-Cell, Peripheral 8Mycosis Fungoides 6Lymphoma, T-Cell, Cutaneous 6Leukemia, B-Cell 6Neoplasms, Plasma Cell 5Neoplasms 5Lymphoma, Extranodal NK-T-Cell 5Lymphoma, B-Cell, Marginal Zone 5Waldenstrom Macroglobulinemia 4Sarcoma 4Primary Myelofibrosis 4Melanoma 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Topotecan 1Imiquimod 1Gadolinium DTPA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Glioma × Lymphoid × Clear all
NCT01678352 2020-02-24

Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas

University of Pittsburgh

Phase EARLY_PHASE1 Completed
19 enrolled
CNSLymphoid

Glioma, Lymphoma, Follicular

NCT02278510 2017-03-31

Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
3 enrolled
CNSLymphoid

Glioma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡